Telomir Pharmaceuticals News

Sector Update: Health Care Stocks Climb Thursday Afternoon

MT NewswiresNov 21 13:50 ET

Sector Update: Health Care

MT NewswiresNov 21 13:33 ET

Telomir Pharmaceuticals Shares Are Trading Higher After the Company Announced Preclinical Results Confirming the Efficacy of Telomir-1.

BenzingaNov 21 11:19 ET

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study With Telomir-1

AccesswireNov 21 07:00 ET

Telomir Pharma Shares Rise 4% After Anti-Aging Drug News

WSJNov 20 18:44 ET

Telomir Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

SECNov 12 16:50 ET · Announcements

Telomir Pharmaceuticals Special Advisor Dr. Michael Roizen to Discuss Telomir-1 and the Science of Longevity on Health Uncensored With Dr. Drew on the Fox Business Network This Sunday

AccesswireSep 26 16:00 ET

Telomir Pharmaceuticals Reaches US$198m Market Cap Benefiting Insider Stock Buying

Simply Wall StSep 21 10:26 ET

Telomir Pharmaceuticals Insider Ups Holding During Year

Yahoo FinanceSep 19 08:38 ET

Telomir Pharmaceuticals Appoints Dr. Itzchak Angel, Former Head of Pharmacology at Synthelabo (Now Sanofi-Aventis), to Lead IND and INAD Applications for Human and Veterinary Indications

AccesswireSep 4 07:30 ET

Telomir Pharmaceuticals Featured in Local ABC Exclusive Showing Positive Outcomes of Proposed Age Reversal Pill in Dogs

AccesswireAug 20 07:30 ET

Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session

BenzingaAug 19 13:37 ET

Telomir Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

SECAug 13 16:09 ET · Announcements

Telomir Pharma: Hugh McColl III, Talhia Tuck and Brad Kroenig Resign From the Board>TELO

Dow JonesAug 12 08:33 ET

Telomir Pharma Names Matthew P. Del Giudice, Ned MacPherson and Matthew Pratt Whalen to Board >TELO

Dow JonesAug 12 08:33 ET

Telomir Pharmaceuticals Appoints Erez Aminov as CEO and Chairman of the Bd >TELO

Dow JonesAug 12 08:32 ET

Press Release: Telomir Pharmaceuticals Mourns the Passing of Chairman and CEO Dr. Christopher Chapman

Dow JonesAug 12 08:30 ET

Individual Investors Are Telomir Pharmaceuticals, Inc.'s (NASDAQ:TELO) Biggest Owners and Were Rewarded After Market Cap Rose by US$24m Last Week

Yahoo FinanceAug 9 09:13 ET

Telomir Pharmaceuticals Added to Membership of Russell 3000 and Russell Microcap Indexes

GlobeNewswireJul 2 08:30 ET

Telomir Pharmaceuticals Scientific Advisor to Participate in Drug Information Association 2024 Global Annual Meeting Panel

GlobeNewswireJun 17 16:10 ET